Generation Bio

Generation Bio OCF Margin

Delisted

The Operating Cash Flow Margin of Generation Bio (GBIO) as of Nov 10, 2026 is -445.22 %. In the previous year, Operating Cash Flow Margin was -893.38 % — a change of -50.16% (higher).

OCF Margin

-445.22 %

YoY

-50.16%

Last updated:

Operating Cash Flow Margin of Generation Bio is 2024 -445.22 % . Operating Cash Flow Margin of Generation Bio was 2023 -893.38 % . It decreases by -50.16% higher compared to the previous year.

The Generation Bio OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
-78,108.33 USD
Jan 1, 2022
-11,641.82 USD
Jan 1, 2023
-893.38 USD
Jan 1, 2024
-445.22 USD
The Generation Bio OCF Margin history
YEAROCF MarginYoY
-445.22 %-50.16%
-893.38 %-92.33%
-11,641.82 %-85.10%
-78,108.33 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Generation Bio Stock analysis

What does Generation Bio do? Generation Bio Co. is a genetic medicines company headquartered in Cambridge, Massachusetts, that focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. The firm is developing a class of gene therapy utilizing its non-viral gene therapy platform to deliver genetic payloads to a range of tissues. The company’s non-viral gene therapy platform includes its DNA construct called closed-ended DNA (ceDNA), its cell-targeted lipid nanoparticle delivery system (ctLNP) and its established, scalable capsid-free manufacturing process. The firm is engineering its gene therapies to be redosable, which enable patient titration to reach the desired therapeutic expression and to maintain efficiency in a patient’s life. The firm is a preclinical stage company and have not identified a product candidate. Generation Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Generation Bio stock

Operating Cash Flow Margin of Generation Bio is -445.22 % in 2024.

Operating Cash Flow Margin of Generation Bio changed from -893.38 % to -445.22 %, representing a -50.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Generation Bio since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Generation Bio with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Generation Bio

All Key Metrics — Generation Bio